Citigroup Inc. Sells 8,509 Shares of Globe Life Inc. $GL

Citigroup Inc. lessened its holdings in shares of Globe Life Inc. (NYSE:GL) by 12.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 59,344 shares of the company’s stock after selling 8,509 shares during the period. Citigroup Inc. owned 0.07% of Globe Life worth $8,484,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Synergy Asset Management LLC boosted its position in Globe Life by 1,022.7% during the third quarter. Synergy Asset Management LLC now owns 100,603 shares of the company’s stock valued at $14,240,000 after acquiring an additional 91,642 shares during the last quarter. Allianz Asset Management GmbH boosted its position in shares of Globe Life by 55.2% during the 3rd quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock valued at $11,761,000 after purchasing an additional 29,256 shares in the last quarter. Retirement Systems of Alabama acquired a new stake in Globe Life during the third quarter worth approximately $2,470,000. SteelPeak Wealth LLC bought a new stake in Globe Life in the third quarter worth approximately $2,985,000. Finally, MGO One Seven LLC acquired a new position in Globe Life in the third quarter valued at approximately $1,364,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Board raised the quarterly dividend to $0.33 (22.2% increase) and announced two new board members — supports income-focused investors and signals confidence in cash flow. GLOBE LIFE INC. DECLARES DIVIDEND AND ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
• Positive Sentiment: Wells Fargo published a positive price-forecast note on Globe Life, which can attract buyers and lend near-term support to the share price. Wells Fargo & Company Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price
• Neutral Sentiment: Globe Life Field booked for an Eagles concert, which forced a local high school to reschedule prom — shows strong event demand and venue utilization but has minimal direct impact on insurance operations. Eagles concert at Globe Life Field moves Texas high school’s prom night date How an Eagles concert at Globe Life Field bumped a North Texas high school prom
• Neutral Sentiment: GL was included in a Zacks piece highlighting high-ROE stocks as resilient plays; such coverage may raise investor interest but is not a company-specific catalyst. Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
• Negative Sentiment: CEO James Matthew Darden sold 9,527 shares (~15% reduction in his reported ownership), a sizable insider sale that can spook some investors. SEC Form 4 – Darden sale
• Negative Sentiment: EVP Robert Edward Hensley sold 712 shares (~7.7% reduction in his holding), another insider sale that adds to selling pressure signals. SEC Form 4 – Hensley sale
• Negative Sentiment: TipRanks flagged Globe Life’s rising allocation to alternative assets as increasing volatility, capital strain and liquidity risk — a potential medium-term headwind for valuation if realized. Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk

Globe Life Stock Performance

Shares of Globe Life stock opened at $145.32 on Monday. The company has a market cap of $11.43 billion, a PE ratio of 10.32 and a beta of 0.46. Globe Life Inc. has a 52 week low of $109.38 and a 52 week high of $152.71. The business has a 50 day moving average price of $141.88 and a 200-day moving average price of $138.72. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.39.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The company had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the firm earned $3.14 EPS. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be issued a $0.33 dividend. This is an increase from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Thursday, April 2nd. Globe Life’s dividend payout ratio is currently 7.67%.

Insider Activity at Globe Life

In related news, CEO Frank M. Svoboda sold 12,500 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the transaction, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,192,969.04. This trade represents a 25.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO James Matthew Darden sold 9,527 shares of the company’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $144.34, for a total transaction of $1,375,127.18. Following the completion of the sale, the chief executive officer directly owned 53,860 shares of the company’s stock, valued at $7,774,152.40. The trade was a 15.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 73,868 shares of company stock valued at $10,700,437 over the last three months. Insiders own 1.97% of the company’s stock.

Wall Street Analyst Weigh In

GL has been the subject of several recent analyst reports. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. Morgan Stanley restated an “overweight” rating and issued a $176.00 price target on shares of Globe Life in a report on Monday, December 15th. Wells Fargo & Company upped their price objective on shares of Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. Truist Financial raised their target price on Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research note on Friday, February 6th. Finally, JPMorgan Chase & Co. upped their price target on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Eight equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $171.33.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.